157 related articles for article (PubMed ID: 36226249)
21. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
22. Fluorene-9-bisphenol inhibits epithelial-mesenchymal transition of human endometrial cancer Ishikawa cells by repressing TGF-β signaling pathway.
Wang L; Zhuang T; Li F; Wei W
Environ Sci Pollut Res Int; 2019 Sep; 26(26):27407-27413. PubMed ID: 31327139
[TBL] [Abstract][Full Text] [Related]
23. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
Cao C; Zhou JY; Xie SW; Guo XJ; Li GT; Gong YJ; Yang WJ; Li Z; Zhong RH; Shao HH; Zhu Y
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284427
[TBL] [Abstract][Full Text] [Related]
24. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
25. Metformin reduces pancreatic cancer cell proliferation and increases apoptosis through MTOR signaling pathway and its dose-effect relationship.
Zhao HW; Zhou N; Jin F; Wang R; Zhao JQ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5336-5344. PubMed ID: 32495867
[TBL] [Abstract][Full Text] [Related]
26. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM
Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570
[TBL] [Abstract][Full Text] [Related]
28. Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells.
Ding J; Li M; Deng L; Li T
Biomed Res Int; 2018; 2018():8372085. PubMed ID: 30175145
[TBL] [Abstract][Full Text] [Related]
29. [Metformin inhibits proliferation and promotes apoptosis of HER-2 positive breast cancer cells possibly through the Hippo-YAP pathway].
Xu Y; Xu T; Xiong Y; Huang J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):740-746. PubMed ID: 35673919
[TBL] [Abstract][Full Text] [Related]
30. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
[TBL] [Abstract][Full Text] [Related]
32. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
33. lncRNA RHPN1-AS1 promotes the progression of endometrial cancer through the activation of ERK/MAPK pathway.
Zhang XJ; Qi GT; Zhang XM; Wang L; Li FF
J Obstet Gynaecol Res; 2021 Feb; 47(2):533-543. PubMed ID: 33169491
[TBL] [Abstract][Full Text] [Related]
34. Expression of miR-106 in endometrial carcinoma RL95-2 cells and effect on proliferation and invasion of cancer cells.
Li X; Yi X; Bie C; Wang Z
Oncol Lett; 2018 Aug; 16(2):2251-2254. PubMed ID: 30008926
[TBL] [Abstract][Full Text] [Related]
35. Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells.
Du Q; Liu J; Zhang X; Zhang X; Zhu H; Wei M; Wang S
Braz J Med Biol Res; 2018; 51(4):e6803. PubMed ID: 29490000
[TBL] [Abstract][Full Text] [Related]
36. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L
BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639
[TBL] [Abstract][Full Text] [Related]
37. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A.
Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395
[TBL] [Abstract][Full Text] [Related]
38. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
39. IL-24 inhibits endometrial cancer cell proliferation by promoting apoptosis through the mitochondrial intrinsic signaling pathway.
Liao S; Yang Y; Chen S; Bi Y; Huang Q; Wei Z; Qin A; Liu B
Biomed Pharmacother; 2020 Apr; 124():109831. PubMed ID: 31972354
[TBL] [Abstract][Full Text] [Related]
40. Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance.
Liu BJ; Xu QY; Yu WD; Li N; Yao T; Zhao LJ; Wang JL; Wei LH; Li XP
Front Med (Lausanne); 2020; 7():70. PubMed ID: 32258043
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
